Unifilter 96-well Harvester SS system for Radioligand Binding Assays/PCA-NIDA-03204

Tender summary

{"description":"COMBINED SYNOPSIS / SOLICITATION-COMPETITIVE\n\n\n\n\n\nTitle: Unifilter 96-well Harvester SS system for Radioligand Binding Assays         \n\n\n\n\n\tThis is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 as supplemented with additional information included in this notice.  This announcement constitutes the only solicitation; quotes are being requested and a separate written solicitation will not be issued.\n\n\n\n\nThe solicitation number is 75N98026Q00279 and the solicitation is issued as request for quotation (RFQ). \n\n\n\nThis acquisition is for a commercial item and is conducted under the authority of the FAR Part 12—Acquisition of Commercial Items and is not expected to exceed the simplified acquisition threshold. A fixed-price type of purchase order is contemplated for this requirement.\n\n\n\nThe National Institute on Drug Abuse (NIDA), The Medicinal Chemistry Section, requires the purchase of Unifilter 96-well Harvester SS system for Radioligand Binding Assays.\n\n\n\n\n\tThe solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2025-05, dated 08-07-2025.\n\n\n\n\n\n\tThe North American Industry Classification System (NAICS) Code for this procurement is 325413– In-Vitro Diagnostic Substance Manufacturing.\n\n\n\n\nLine Items: Through this procurement NIDA anticipates a single award, firm fixed price purchase order for the following items listed below:  \n\n\n\nAll quotes will be evaluated on (Lowest Price Technically Acceptable) as described in the\n\n\n\nBelow is a table that contains the line item numbers and description of the brand name or equal requirement for the anticipated award. \n \n\nLine No.\n\nDescription\n\n1\n\nUNIFILTER-96 CELL HARVESTER SS\n\nCell Harvester Unifilter-96 well\n\nFeatures and Benefits:\n\n-     Short fluid paths#"minimizes the amount of wash fluid required and ensures more complete washing\n\n-     Separate hot and cold waste liness#"helps minimize radioactive waste\n\n-     Built-in scrubbers make it easy to detach adherent cells from well bottoms and ensure complete harvesting\n\nThe Unifilter-96 Harvester S.S. includes:\n\n-1 FilterMate harvester for UniFilter-24 microplates\n\n-     4 4-liter waste bottles with color coded tubing\n\n-     2 Waste bottle stands\n\n-     1 Tool for converting to UniFilter-96\n\n-     1 Operation manual\n\nPlease note: The Harvester requires a vacuum source capable of at least 4 cubic feet per minute. The harvester also requires a carboy and "tubing, not included with system."\n\n\n\n"Power Requirements: 110-240 V (+/- 10%}, 50/60 Hz, single phase" "Dimensions: Width 80 cm, Depth 71 cm, Height 71 cm"\n\nProduct Weight: 23 kg\n\n\n\n1 YEAR WARRANTY\n\n2\n\nPRESSURIZED WASH BOTTLE STAND\n\n3\n\nVACUUM PUMP KIT, 110V\n\n4\n\nNew Instrument Online Training & Support\n\n5\n\nFREIGHT/SHIPPING AND HANDLING\n\n\n\nDescription Requirement: Radioligand binding assays are a core experimental technique used within the Medicinal Chemistry Section to characterize ligand affinity and pharmacological properties at central nervous system targets. These assays rely on rapid filtration of assay plates to separate bound from free radioligand prior to scintillation counting.\n\n\n\nThe Unifilter 96-well Harvester SS system is designed specifically for high-throughput filtration of 96-well plates used in radioligand binding assays. This instrument allows rapid and consistent harvesting of assay plates onto filter plates, which is essential for maintaining assay integrity and reproducibility when working with radiolabeled compounds.\n\n\n\nThe ability to process multiple plates efficiently is critical for evaluating new compounds synthesized within the Medicinal Chemistry Section and for supporting ongoing structure–activity relationship studies. Acquisition of this system will ensure reliable and efficient processing of radioligand binding assays and support ongoing pharmacological characterization of novel compounds developed within the laboratory.\n\n\n\nExpected Delivery: \n\n30-45 from the date of the award.\n\n\n\nShipping Instructions\n\nNIH/NIDA\n\n333 Cassel Drive\n\nTriad Bldg. RM 3304\n\nBaltimore MD 21224\n\n\n\nPayment\n\nNet 30\n\n\n\nStatutory Authority:\n\n\n\nThis notice is a Combined Synopsis/Solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 “Streamlined Procedures for Evaluation and solicitation for commercial Items,” as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested.\n\n\n\nClosing Statement:\n\n\n\nResponses to this notice must include sufficient information to establish the interested parties’ bona-fide capabilities of providing the product. The response shall include: the unit price, list price, shipping and handling costs, delivery days after contract award, delivery terms, prompt payment discount terms, F.O.B. Point (Destination or Origin), product or catalog number(s); product description; and any other information or factors that may be considered in the award decision.  The government intends to award a firm fixed price purchase order to the responsible contractor as a result of this RFQ that will include the terms and conditions set forth herein.  The award will be based on the following: brand name requirements salient characteristics, price, and delivery.\n\n\n\nBy submitting a quote in response to this solicitation, vendor is accepting the following terms and conditions: \n\n\n\nThe following FAR provisions apply to this acquisition:\n\n\n\nFAR 52.212-1 Instructions to Offerors Commercial Items (SEP 2023)\n\n\n\nFAR 52.212-3 Offerors Representations and Certifications - Commercial Items (OCT 2025)\n\n\n\nFAR 52.204-7 System for Award Management (NOV 2024)\n\n\n\n(Offerors must complete annual representations and certifications on-line at http://www.sam.gov/ in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items (Please ensure FAR 52.209-2 -- Prohibition on Contracting with Inverted Domestic Corporations--Representation. (NOV 2015) is updated in your SAM record)\n\n\n\nFAR 52.203-18 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements – Representation (JAN 2017)\n\n\n\n52.204–26 Covered Telecommunications Equipment or Services-Representation\n\n(OCT 2020)\n\n\n\nFAR 52.211-6 Brand Name or Equal (AUG 1999)\n\n\n\nThe following FAR contract clauses apply to this acquisition:\n\n\n\nFAR 52-212-4 Contract Terms and Conditions Commercial Items (NOV 2023)\n\n\n\nFAR 52-212.5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (JAN 2025)\n\n\n\nFAR 52.217-6 Option for Increased Quantity (MAR 1989)\n\n\n\nFAR 52.232-40 Providing Accelerated Payments to Small Business Subcontractors (MAR 2023)\n\n\n\nFAR 52.204-13 System for Award Management Maintenance (OCT 2018)\n\n\n\nFAR 52.204-25 Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment (NOV 2021)\n\n\n\nHHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (DEC 2015)\n\n\n\nFAR 52.252-2 -- Clauses Incorporated by Reference. (FEB 1998)\n\nThis contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this address:  http://farsite.hill.af.mil/vffara.htm\n\n\n\nBy submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov).\n\n\n\nCopies of the above-referenced provisions and clauses are available from http://www.acquisition.gov/far/loadmainre.html & http: //www.hhs.gov/regulation/index.html or, upon request, either by telephone or fax.\n\n\n\nAll responses must be received by 05/14/2026 @ 10:00 AM EST and must reference announcement / solicitation number: 75N98026Q00279 with response submitted electronically to johnsonjr@mail.nih.gov.  Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f). All responsible sources may submit an offer that will be considered by this Agency.\n\n\n"} Solicitation Number: 75N98026Q00279 Type: Combined Synopsis/Solicitation Base Type: Combined Synopsis/Solicitation NAICS: 325413 Classification Code: 6505 Response Deadline: 2026-05-14T10:00:00-04:00 Office Address: BETHESDA, MD Place of Performance: Baltimore, Maryland, 21224 POC: john johnson, johnsonjr@mail.nih.gov, 6673125580

What to check before bidding

• Located in United States.
• Source notice a816efcae82c492881c66a6a9567b956 on SAM.gov.
• Notice published 29 Apr 2026; Tenqual indexed it 1 May 2026.
• Deadline listed as 14 May 2026.
• Create a free tender alert to catch similar opportunities before the deadline pressure starts.